Equities

Anhui Huaheng Biotechnology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Anhui Huaheng Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)34.30
  • Today's Change-0.46 / -1.32%
  • Shares traded4.11m
  • 1 Year change+15.14%
  • Beta1.6211
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Anhui Huaheng Biotechnology Co Ltd is a China-based company specializing in the research and development, production and sales of amino acids and other bio-based products based on alanine series products. The Company is an enterprise focusing on synthetic biotechnology and mainly engaged in the research and development, production and sales of amino acid and its derivative products. The Company's main products include alanine series products (L-alanine, DL-alanine, β-alanine), calcium D-pantothenate and α-arbutin. The Company's products are mainly used in intermediates, animal nutrition, daily chemical care, functional food and nutrition, plant nutrition and other fields. The Company distributes its products and services within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)2.83bn
  • Net income in CNY187.25m
  • Incorporated2005
  • Employees2.19k
  • Location
    Anhui Huaheng Biotechnology Co LtdNo. 197 Chang'an Road, Gaoxin DistrictHEFEI 231031ChinaCHN
  • Phone+86 55 165689046
  • Fax+86 55 165689468
  • Websitehttps://www.huahengbio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhongyin Babi Food Co Ltd1.82bn283.42m6.89bn2.09k24.423.04--3.791.181.187.599.460.642616.9719.47867,870.809.9710.1312.0612.3326.9526.8015.5116.782.46--0.022339.582.539.4529.4212.3226.21--
Juewei Food Co Ltd5.50bn68.93m7.62bn5.03k111.161.19--1.390.11320.11329.0010.530.64014.6924.981,094,997.000.55556.190.69967.6629.3628.910.86797.430.872.660.105251.39-13.843.88-34.04-22.29-9.473.52
Namchow Food Group Shanghai Co Ltd3.12bn79.93m7.66bn1.86k93.842.25--2.450.19230.19237.618.030.74464.4215.721,679,683.001.916.882.298.8019.4327.252.569.022.45--0.094230.122.496.09-13.34-7.564.91--
Beijing Sanyuan Foods Co Ltd6.49bn187.42m7.83bn5.91k41.571.50--1.210.12530.12534.263.470.69338.078.861,097,061.001.790.99642.811.6221.2923.662.581.670.5059--0.288628.34-10.57-2.96-77.41-16.41-12.64-14.97
Zhejiang Yiming Food Co Ltd2.84bn38.45m8.00bn4.15k208.097.10--2.820.09590.09597.082.810.99115.8513.84683,884.301.340.59242.931.0927.2931.371.350.61750.51365.500.3369164.364.096.6230.16-30.14-13.56--
Toly Bread Co Ltd5.49bn385.11m8.53bn8.39k22.141.63--1.550.24070.24073.433.260.75825.4313.40654,156.005.3210.746.6912.8221.3025.197.0210.630.681934.010.182573.11-9.931.52-9.05-5.24-5.97-10.08
Anhui Huaheng Biotechnology Co Ltd2.83bn187.25m8.58bn2.19k45.453.20--3.030.75470.754711.4910.720.5465.1811.361,292,765.003.3911.284.8916.0721.5234.236.2117.771.006.730.439528.9212.3734.69-57.808.4462.41--
Jiangsu Hengshun Vinegar Industry Co Ltd2.29bn148.94m8.72bn2.02k57.742.60--3.800.13650.13652.173.040.55386.3950.801,134,835.003.294.433.955.6034.3635.995.947.342.5552.890.000970.584.253.6946.54-17.0716.32-9.17
Snowsky Salt Industry Group Co Ltd4.48bn-2.28m9.96bn5.71k--1.32--2.22-0.0014-0.00142.714.590.39619.9526.56784,513.300.08075.860.11178.2019.7728.220.20369.741.524.810.051949.96-13.9018.87-57.1315.6318.4838.62
Guangzhou Restaurant Group Co Ltd5.31bn495.26m10.12bn5.70k20.422.55--1.910.87180.87189.336.970.696311.5212.56930,602.606.8310.3411.0214.6330.2435.669.8112.521.01--0.235144.894.5511.09-10.295.15-1.3517.50
Data as of Feb 13 2026. Currency figures normalised to Anhui Huaheng Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

12.65%Per cent of shares held by top holders
HolderShares% Held
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 202517.06m7.47%
E Fund Management Co., Ltd.as of 30 Jun 20253.82m1.67%
China Southern Asset Management Co., Ltd.as of 30 Jun 20251.47m0.64%
China Asset Management Co., Ltd.as of 30 Jun 20251.44m0.63%
Bosera Asset Management Co., Ltd.as of 30 Jun 20251.11m0.49%
Huashang Fund Management Co., Ltd.as of 30 Jun 20251.07m0.47%
Penghua Fund Management Co., Ltd.as of 30 Jun 20251.05m0.46%
The Vanguard Group, Inc.as of 04 Feb 2026679.01k0.30%
GF Fund Management Co., Ltd.as of 30 Jun 2025657.65k0.29%
Yinhua Fund Management Co., Ltd.as of 30 Jun 2025529.70k0.23%
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.